![]()
And then we produce them in a sterile way, according to that CGMP standard. We talked to them about the kinds of drug products they need in the concentration and fill volumes. So the way we go from idea to product is we talk to hospitals about what they need. To make sure that it's sterile well, it's up to us then to prove that we adequately monitor our environment when the FDA comes into inspect us. VISTA EQUITY PARTNERS STANDARD OPERATING PROCEDURES CODEit follows parts two, 10 and two 11 of the code of the federal register.Īnd, so there are some things that are specific in there, but there are other things that say, you must monitor your environment. And what that is, it's somewhat of an interpreted standard. ![]() Procedures, some people say process, but C, G, M P is the acronym we all understand. We follow, an FDA, guidance and guideline called current good manufacturing. Joe Bagan: How does that, yeah, so it's a very difficult process. VISTA EQUITY PARTNERS STANDARD OPERATING PROCEDURES HOW TOAnd then I guess, how does the process work for you? How to things, how does a product go from, being ready to be put in injectable to finally working with your company? And, really our customers are just hospitals and healthcare systems.ĭon Davis Phd, MBA: Okay. we can fill prescriptions here, but we don't. We don't sell anything to the general public. the key though, is they're all used in hospitals. and usually through an intravenous solution, drip into the person, common anesthesia drugs, we do those common pain drugs. coming out of our facility, it's all going through the vein. They're all the things you'd need during a, either a surgical procedure or any other procedure where you're going to put something directly into the body. they're the things that, take your heartbeat down, raise your heartbeat. So all of our products are used in operating room, ICU, ER, they're the sterile injectables that put you to sleep, wake you up, drop your blood pressure, raise your blood pressure. it stands for safety, transparency, availability, and quality, and, we make sterile injectable products for hospital and healthcare systems. Joe Bagan: Yeah, so stack is our not only our namesake, but our mission as well. And so I guess the, then the next thing I'd like to explore a little bit about is, so what is stack and what is it that you're doing? What are you working on? We all know as glow bill, which very few Denverites really know where that is, but those that have been around a long time do and, understand, what part of the city I grew up in.ĭon Davis Phd, MBA: thank you so much for that. Both of my parents were born here in Denver and I grew up in an industrial neighborhood. One thing that's interesting about me as a, not only have I lived here all my life. a different st Joe's hospital than the one, today. So I'm a Denver native and, one, born in Denver at st. I looked, I've looked quite a bit at your past and, I know that right now you're at STAC pharma, so I'm wanting to, just, explore a little bit of your past and, tell us a little bit about you. Happy to be here.ĭon Davis Phd, MBA: Yeah. So today I'd like to welcome to the podcast, Joe Bagan Joe. Joe graduated from the university of Denver in 1988. Joe led the Southwestern United States consulting practice and telecommunications and media. ![]() CAO at Adelphia and CFO at ricochet wireless network, Joe has also led larger organizations as he served in various executive capacities at and T broadband from 2000 to 2003 prior to 18 T Joe was a partner at Arthur Anderson. These include COO of clear channel outdoor as VP of Adelphia communications in the Southeast region of the United States. VISTA EQUITY PARTNERS STANDARD OPERATING PROCEDURES TVBefore his work in life sciences, Joe held a number of executive positions in the telecommunications cable, TV and media industries. He's also the co-founder of rev gen incorporated a consultancy focused on data analytics, business intelligence systems and development of applications for companies of all sizes. Founded and developed an anti-microbial peptide antibiotic, and as an advisor to drug company and medical device companies through the Colorado university innovation program, spark Joe brings more than 25 years of strategic leadership and executive management experience. ![]() Joe's also led genomic data gathering and analytical efforts for a cancer consortium or Ryan. Joe was previously founder, CEO, and then chairman of Sharklet technology until it was acquired in 2017 by a Chinese private equity firm, specializing in biotechnology. I'd like to welcome to the podcast, Joe Baygon Joe's currently the founder and CEO of stack pharma, a highly automated five Oh three B outsourcing entity. That scale to meet the needs of people in our world.ĭon Davis Phd, MBA: Yeah. We cover their proven methods, principles, strategies, and mindsets to implement new technologies. Intro: On this podcast, find interviews with high performing successful individuals in life sciences on a weekly basis. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |